Compound
D1125 | tibrofan
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 0.79±0.11 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 0.87 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 16.96±6.90 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 15686-72-3 | 2-Thiophenecarboxamide, 4,5-dibromo-N-(4-bromophenyl)- | 2K1U70U1M5 |
| 4,4',5-Tribromo-2-thiophenecarboxyanilide | 4,5-dibromo-N-(4-bromophenyl)thiophene-2-carboxamide | AKOS001354723 |
| CAS-15686-72-3 | CHEMBL1315136 | D06134 |
| DSSTox_CID_26156 | DSSTox_GSID_46156 | DSSTox_RID_81387 |
| DTXSID9046156 | MCULE-6350568360 | NCGC00160448-01 |
| NCGC00160448-02 | Q27254847; | SCHEMBL2110124 |
| SR-01000944960 | SR-01000944960-1 | TIBROFAN |
| Tibrofan (USAN/INN) | Tibrofan [USAN:INN] | Tox21_111818 |
| UNII-2K1U70U1M5 | ZINC538456 |